NCT00267215View on ClinicalTrials.gov

Efficacy and Safety of Lumiracoxib

PHASE3CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

November 30, 2000

Primary Completion Date

February 28, 2001

Conditions
Osteoarthritis
Interventions
DRUG

Lumiracoxib

Trial Locations (1)

Unknown

Novartis, Nuremberg

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00267215 - Efficacy and Safety of Lumiracoxib | Biotech Hunter | Biotech Hunter